title: Mitogen stimulation of canine normal and myasthenia gravis lymphocytes.
abstract: Responses of canine lymphoid tissues to mitogens were studied in five normal dogs and in two dogs with acquired myasthenia gravis (MG). In the normal dogs, lymph-node-derived lymphocytes gave the most consistent proliferative responses to concanavalin A (Con A), phytohemagglutinin (PHA), and pokeweed mitogen (PWM), as determined by thymidine incorporation; and in most cases PHA, lipopolysaccharide (LPS), and PWM stimulated total IgG production, as determined by ELISA. Splenic lymphocytes had the greatest capacity for increased total IgG production. In the myasthenic dogs total IgG production by unstimulated lymph-node-derived lymphocytes was 88 micrograms/ml and 153 micrograms/ml, much higher than that of unstimulated normal dog lymphocytes (mean less than 1.0 microgram/ml). All mitogens resulted in suppression rather than stimulation of IgG production by lymphocytes from dogs with MG. Production of antibodies to acetylcholine receptors (AChRs) was detected in the supernatants of lymphocyte cultures from one of the dogs with MG at a rate of 78 fmol/5 x 10(5) cells per week and was not detected in culture supernatants of control dogs. This study demonstrates that lymph nodes may be an important site of antibody production in myasthenic dogs and provides the necessary groundwork for future studies of the cellular immunology of canine MG.
authors.affiliation: Salk Institute for Biological Studies, San Diego, CA 92138.
authors.forename: G D
authors.initials: GD
authors.lastname: Shelton
authors.forename: Y
authors.initials: Y
authors.lastname: Fujii
authors.forename: J
authors.initials: J
authors.lastname: Lindstrom
mesh_terms: D000818:Animals; D002478:Cells, Cultured; D004283:Dog Diseases / Q000276:immunology*; D004285:Dogs; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D007074:Immunoglobulin G / Q000096:biosynthesis / Q000276:immunology; D008198:Lymph Nodes / Q000166:cytology / Q000276:immunology; D008213:Lymphocyte Activation / Q000187:drug effects*; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology*; D008297:Male; D008934:Mitogens / Q000494:pharmacology*; D009157:Myasthenia Gravis / Q000276:immunology / Q000662:veterinary*; D011950:Receptors, Cholinergic / Q000276:immunology; D013154:Spleen / Q000166:cytology / Q000276:immunology
chemical_list: D007074:Immunoglobulin G; D008934:Mitogens; D011950:Receptors, Cholinergic